ABCB approaches its April 30 earnings release with options traders leaning hard to the upside. The put/call ratio has collapsed to 0.07, more than 1.2 standard deviations below its 20-day mean of 0.17 — close to the lowest reading of the past year. That is a sharp reversal from April's first half, when the PCR held steadily near 0.22, and it reflects a clear shift toward call positioning in the days immediately ahead of the print.
The bullish options tilt follows a strong month for the stock. ABCB has gained 12% over the past month to close at $85.12, even as the broader regional bank peer group struggled. Its closest correlated peers — UBSI, HWC, UCB, and ONB — all fell between 2% and 4% on the week. ABCB, by contrast, ended the week essentially flat, down just 0.4%. That relative resilience stands out in a sector still digesting macro rate uncertainty.
Short interest does not suggest a squeeze-prone setup. Bears hold just 3.8% of the free float, and while that number has crept up from roughly 2.9% in mid-March, utilization has eased back to 5.2% — well below the 52-week high of 6.7% hit at end-March. Borrow costs are a negligible 0.45% and drifting lower, down about 16% on the week. There is no meaningful pressure in the lending market.
The analyst debate is a cautious one. Two firms — Stephens and Truist — raised targets on Monday, to $90 and $89 respectively, but kept neutral-leaning ratings. DA Davidson remains the outlier bull with a $94 Buy. KBW sits at Outperform with an $88 target, last updated in February. The mean target of $93.50 implies modest single-digit upside from current levels. Bears point to NIM compression risk, a flat yield curve, and the potential for credit deterioration in commercial real estate — the same loan book that drove recent growth. Bulls cite consistent loan growth in the mid-single digits, construction and CRE real estate contributions, and a track record of beating estimates. A cluster of executives, including the CEO, sold shares in late February at around $79, though those transactions were small in absolute terms and the stock has since moved appreciably higher.
April 30's print is ultimately a test of whether ABCB's loan growth momentum and credit quality can justify a valuation that, at 12.4x earnings and 1.27x book, has expanded materially over the past month — even as peers pulled back.
See the live data behind this article on ORTEX.
Open ABCB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
